- Home
- FBIO vs CALC Comparison
FBIO vs CALC Comparison
Compare FBIO & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIO
- CALC
- Stock Information
- Founded
- FBIO 2006
- CALC 2011
- Country
- FBIO United States
- CALC United States
- Employees
- FBIO N/A
- CALC N/A
- Industry
- FBIO Biotechnology: Pharmaceutical Preparations
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- FBIO Health Care
- CALC Health Care
- Exchange
- FBIO Nasdaq
- CALC Nasdaq
- Market Cap
- FBIO 39.4M
- CALC 36.0M
- IPO Year
- FBIO N/A
- CALC N/A
- Fundamental
- Price
- FBIO $1.62
- CALC $2.35
- Analyst Decision
- FBIO Strong Buy
- CALC Strong Buy
- Analyst Count
- FBIO 3
- CALC 5
- Target Price
- FBIO $18.00
- CALC $18.20
- AVG Volume (30 Days)
- FBIO 277.9K
- CALC 32.0K
- Earning Date
- FBIO 03-27-2025
- CALC 03-27-2025
- Dividend Yield
- FBIO N/A
- CALC N/A
- EPS Growth
- FBIO N/A
- CALC N/A
- EPS
- FBIO N/A
- CALC N/A
- Revenue
- FBIO $81,501,000.00
- CALC N/A
- Revenue This Year
- FBIO N/A
- CALC N/A
- Revenue Next Year
- FBIO $128.63
- CALC N/A
- P/E Ratio
- FBIO N/A
- CALC N/A
- Revenue Growth
- FBIO 31.51
- CALC N/A
- 52 Week Low
- FBIO $1.36
- CALC $2.05
- 52 Week High
- FBIO $2.89
- CALC $6.27
- Technical
- Relative Strength Index (RSI)
- FBIO 33.40
- CALC 35.06
- Support Level
- FBIO $1.65
- CALC $2.36
- Resistance Level
- FBIO $1.85
- CALC $2.66
- Average True Range (ATR)
- FBIO 0.10
- CALC 0.24
- MACD
- FBIO -0.01
- CALC -0.02
- Stochastic Oscillator
- FBIO 7.32
- CALC 4.13
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.